Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02302196 · ClinicalTrials.gov registry record

Autologous Fat Grafting of the Breast in Women With Post Lumpectomy Contour Defects

A clinical trial, sponsored by Kaiser Permanente.

Completed
Registry status
27
Enrollment target

NCT02302196: Completed study, sponsored by Kaiser Permanente.

NCT02302196 is a clinical trial that has completed, run by Kaiser Permanente. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02302196 has completed, sponsored by Kaiser Permanente.

COMPLETED
Registry status
27 participants
Enrollment target

Study Summary

The purpose of the study is to evaluate the safety and efficacy of breast reconstruction using Autologous Fat Grafting (AFG) for women post lumpectomy that have contour defects. The study hypothesis is that AFG has emerged as a less invasive alternative to breast reconstruction post mastectomy. AFG could be used to treat breast contour defects with much less invasive outpatient surgery, using the patient's own cells and tissues, which overall reduces risk.

Primary Outcome

The experimental AFG group will have the same or less change in the BIRADS scores than the control non-AFG group.

Interventions

  • OTHER Control Arm
  • PROCEDURE Autologous Fat Grafting of the Breast

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2015-09
Est. Completion 2021-07-13
Kaiser Permanente

294 total trials

What the finished NCT02302196 record still lists

NCT02302196 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target.

The record links to 0 conditions, and to 2 interventions - of which Control Arm is the first listed.

NCT02302196 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02302196 about?

NCT02302196 is a clinical study titled "Autologous Fat Grafting of the Breast in Women With Post Lumpectomy Contour Defects". The purpose of the study is to evaluate the safety and efficacy of breast reconstruction using Autologous Fat Grafting (AFG) for women post lumpectomy that have contour defects. The study hypothesis is that AFG has emerged as a less invasive alternative to breast reconstruction post mastectomy. AFG...

What is the current status of trial NCT02302196?

This trial is currently completed. The enrollment target is 27 participants. The study started on 2015-09. Estimated completion is 2021-07-13.

What interventions are being tested in trial NCT02302196?

The interventions under investigation include: Control Arm (OTHER), Autologous Fat Grafting of the Breast (PROCEDURE).

Who is sponsoring clinical trial NCT02302196?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00912041 · 27 participants · NA

    BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

  • NCT02847559 · 27 participants · Phase 2

    Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

  • NCT03380195 · 27 participants · NA

    Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness

  • NCT03384238 · 27 participants · Phase 1

    Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02302196, the US trial registry maintained by the National Library of Medicine. NCT02302196 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.